Article
480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12
Journal for ImmunoTherapy of Cancer
(2020)
Publication Date
November 1, 2020
DOI
10.1136/JITC-2020-SITC2020.0480
Citation Information
Shawn M Jensen, Christopher Twitty, Christopher Paustian, Madelein Laws, et al.. "480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12" Journal for ImmunoTherapy of Cancer Vol. 8 (2020) Available at: http://works.bepress.com/brian-piening/9/